| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | TWST Twist Bioscience Corp | Green Paula | SVP Of Human Resources | Sell | 9,724 | $32.19 | $312,986.39 | -7.8% | |
| Oct 6, 2025 | TWST Twist Bioscience Corp | Finn Patrick John | President And COO | Sell | 23,747 | $32.19 | $764,344.69 | -10.2% | |
| Oct 6, 2025 | TWST Twist Bioscience Corp | Cho Dennis | See Remarks | Sell | 3,876 | $32.19 | $124,756.81 | -3.8% | |
| Oct 6, 2025 | TWST Twist Bioscience Corp | Laponis Adam | Chief Financial Officer | Sell | 5,875 | $32.19 | $189,098.63 | -5.7% | |
| Oct 6, 2025 | TWST Twist Bioscience Corp | Leproust Emily M. | Chief Executive Officer | Sell | 31,348 | $32.19 | $1,008,998.08 | -5.0% | |
| Oct 6, 2025 | TWST Twist Bioscience Corp | Werner Robert F. | Chief Accounting Officer | Sell | 2,041 | $32.19 | $65,693.67 | -4.2% | |
| Oct 2, 2025 | TWST Twist Bioscience Corp | Cho Dennis | See Remarks | Sell | 124 | $29.16 | $3,615.96 | -0.1% | |
| Oct 2, 2025 | TWST Twist Bioscience Corp | Leproust Emily M. | Chief Executive Officer | Sell | 476 | $29.16 | $13,880.64 | - | |
| Oct 2, 2025 | TWST Twist Bioscience Corp | Green Paula | SVP Of Human Resources | Sell | 140 | $29.16 | $4,082.54 | -0.1% | |
| Oct 2, 2025 | TWST Twist Bioscience Corp | Finn Patrick John | President And COO | Sell | 206 | $29.16 | $6,007.17 | - | |
| Oct 2, 2025 | CSTL Castle Biosciences Inc | Maetzold Derek J | Pres. &Chief Exec. Officer | Sell | 1,339 | $22.58 | $30,234.62 | -2.0% | |
| Oct 2, 2025 | GRAL Grail, Inc. | Ofman Joshua J. | President | Sell | 9,692 | $64.00 | $620,312.23 | -2.0% | |
| Oct 1, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 3,000 | $159.99 | $479,968.90 | -0.8% | |
| Oct 1, 2025 | PRPO Precipio, Inc. | Sabet Ahmed Zaki | Chief Operating Officer | Buy | 25 | $19.50 | $487.50 | +3.6% | |
| Oct 1, 2025 | VCYT Veracyte, Inc. | McGuire Annie | SVP, General Counsel | Sell | 2,160 | $35.00 | $75,607.56 | -2.4% | |
| Oct 1, 2025 | VCYT Veracyte, Inc. | Leite John | Chief Commercial Officer-clia | Sell | 2,539 | $35.00 | $88,865.00 | -2.8% | |
| Oct 1, 2025 | NOTV Inotiv, Inc. | Neff R Matthew | Director | Sell | 2,000 | $1.43 | $2,857.80 | -1.4% | |
| Oct 1, 2025 | VCYT Veracyte, Inc. | Epstein Robert S | Director | Sell | 21,473 | $35.08 | $753,204.13 | -25.6% | |
| Oct 1, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard | CEO And President | Sell | 14,083 | $160.00 | $2,253,233.19 | -2.2% | |
| Sep 30, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin | Chief Financial Officer | Sell | 2,715 | $107.68 | $292,360.70 | -29.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.